CAS: 1831144-46-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-(3-(5-Chloro-2-(difluoromethoxy)phenyl)-1-(2-(4-((2-cyanoethyl)(methyl)amino)piperidin-1-yl)-2-oxoethyl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide REF: IN-DA024AGBCAS: 1831144-46-7 | 97% | A consultar | Mar 05 Nov 24 |
 | GDC-0214 REF: TM-T9826CAS: 1831144-46-7 | 98.54% | 96,00 €~1.130,00 € | Mar 12 Nov 24 |
N-(3-(5-Chloro-2-(difluoromethoxy)phenyl)-1-(2-(4-((2-cyanoethyl)(methyl)amino)piperidin-1-yl)-2-oxoethyl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
CAS:1831144-46-7
Fórmula:
C28H28ClF2N9O3
Pureza:
97%
Forma y color:
Solid
Peso molecular:
612.0302
Ref: IN-DA024AGB
| 1g | A consultar | ||
| 5mg | 147,00 € | ||
| 10mg | 250,00 € | ||
| 25mg | 659,00 € | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 5 de Noviembre de 2024
GDC-0214
CAS:1831144-46-7
GDC-0214 is an inhaled small-molecule JAK1 inhibitor and reduces fractional exhaled nitric oxide (Feno).
Fórmula:
C28H28ClF2N9O3
Pureza:
98.54%
Forma y color:
Solid
Peso molecular:
612.03
Ref: TM-T9826
| 1mg | 96,00 € | ||
| 5mg | 187,00 € | ||
| 10mg | 276,00 € | ||
| 25mg | 441,00 € | ||
| 50mg | 628,00 € | ||
| 100mg | 844,00 € | ||
| 200mg | 1.130,00 € | ||
| 1mL*10mM (DMSO) | 253,00 € |
Entrega estimada en Estados Unidos, el Martes 12 de Noviembre de 2024
